Tulathromycin

We are the first GMP-certified manufacturer of Tulathromycin API in China, with the world’s biggest annual capacity of 70 MT. Our production site of Tulathromycin has been successfully inspected by the US FDA and our product has obtained Free Sales Certificates. Its ASMF is acceptable for use by regulatory bodies such as EMA, Health Canada, V.M.D., Swissmedic, etc. We also manufacture Tulathromycin Injection using self-produced API. This injection is used for the prevention and treatment of acute and chronic swine respiratory diseases caused by Mycoplasma hyopneumoniae, Pasteurella multocida, Actinobacillus pleuropneumoniae, Haemophilus parasuis, and Bordetella bronchiseptica. The recommended administration is via intramuscular injection at a dosage of 2.5mg per 1kg of swine body weight (1ml/40kg of body weight). The dose at each injection site should not exceed 2ml. It is available in 50ml:5g and 100ml:10g specifications. The withdrawal period for swine is 33 days.